However, clinical data are not consistent: in adult patients with CML reduced osteocalcin levels [5] as well as elevated osteocalcin and PINP levels have been reported after 3 months of imatinib treatment. The gene discussed is BGLAP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.